[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637828":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":49,"collaborators":10,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":71,"overallStatus":76,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cardiac Sarcoidosis Patients",null,"Patients with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.",[13],"Other: Exosome Analysis",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Exosome Analysis","Blood Samples will undergo exosome profiling using mass spectrometry and\u002For other discovery-based approaches",[9],[20],{"name":21,"affiliation":5,"role":22},"Andrew Rosenbaum, MD","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Anna Pick","CONTACT","507-255-0630","pick.anna@mayo.edu",[30],{"facility":31,"status":10,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Mayo Clinic in Rochester","Rochester","Minnesota","55905","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-92.4699,44.02163,{"lat":41,"lon":40},[44,45,48],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":21,"role":26,"phone":46,"phoneExt":10,"email":47},"(507) 284-0783","Rosenbaum.Andrew@mayo.edu",{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":22,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Andrew N Rosenbaum","Principal Investigator","100637828","exosome-based-omic-signatures-of-disease-activity-in-cardiac-sarcoidosis-exodacs-100637828",false,"NCT07604220","Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)","EXODACS","Inclusion Criteria\n\n* Adults ≥18 years.\n* Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.\n* Undergoing FDG-PET as part of standard care.\n* Ability to provide informed consent.\n\nExclusion Criteria\n\n• Inability to provide informed consent.","ALL","18 Years",{"count":62,"type":63},115,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.",[67,68,69,70],"Cardiac Sarcoidosis","Sarcoidosis of the Heart","Sarcoidosis With Myocarditis","Sarcoidosis, Cardiac",[72,73,74,75],"cardiac sarcoidosis","FDG-PET","disease activity","proteomics","NOT_YET_RECRUITING","2026-05-18",{"date":79,"type":80},"2026-05-22","ACTUAL",{"date":82,"type":63},"2026-07",{"date":84,"type":63},"2028-07",{"name":5,"class":6},1]